Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

754 questions · 769 findings · 35 reviews · Kidney and Transplant

No studies found 228 · 29.6%GRADE not reported 3 · 0.4%Very low 215 · 28%Low 245 · 31.9%Moderate 74 · 9.6%High 4 · 0.5%

Surgical thrombectomy vs different types of endovascular interventions

Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts

It is very uncertain whether surgical thrombectomy changes patency at 30 days compared with different types of endovascular interventions (very low certainty).

1 finding from 1 review

Surgical thrombectomy vs different types of endovascular interventions

Technical success · thrombosed haemodialysis arteriovenous fistulas and grafts

It is very uncertain whether surgical thrombectomy changes technical success compared with different types of endovascular interventions (very low certainty).

1 finding from 1 review

Surgical thrombectomy vs different types of endovascular interventions

Major adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts

It is very uncertain whether surgical thrombectomy changes major adverse events compared with different types of endovascular interventions (very low certainty).

1 finding from 1 review

Surgical thrombectomy vs different types of endovascular interventions

Minor adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts

It is very uncertain whether surgical thrombectomy changes minor adverse events compared with different types of endovascular interventions (very low certainty).

1 finding from 1 review

Azathioprine vs cyclophosphamide

Relapse · adults with renal vasculitis for maintenance therapy

Azathioprine showed no clear difference in relapse at 18 months compared with cyclophosphamide (moderate certainty).

2 findings from 1 review

Azathioprine vs cyclophosphamide

Serious adverse events · adults with renal vasculitis for maintenance therapy

Azathioprine showed no clear difference in serious adverse events compared with cyclophosphamide (moderate certainty).

1 finding from 1 review